{
    "nctId": "NCT02854644",
    "briefTitle": "Study of the Anti-tumoral Immune Response",
    "officialTitle": "Study of the Anti-tumoral Immune Response T Cells Cluster of Differentiation 4 (TCD4): Proof of the Concept in Breast Cancer and Glioma",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Glioma",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "BASIC_SCIENCE",
    "enrollmentCount": 167,
    "primaryOutcomeMeasure": "Spontaneous immune responses of T cells CD4 specific tumor antigens",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Performance status 0,1 or 2\n* breast cancer or glioma\n* Arm glioma: patients without anti-tumoral treatment\n* Arm breast cancer: inclusion before treatment\n* Arm breast cancer HER2: patients with current therapy\n\nExclusion Criteria:\n\n* Psychiatric disease compromising the understanding of the information or the realization of the study\n* vulnerable People according to the law (minors, adults under protection, private persons of freedom ...)\n* Unaffiliated People to the Social Security\n* People being for the period of exclusion from another study\n* Life expectancy estimated unless 3 months.\n* For patients in Arm glioma: patients having already begun a systematic treatment.\n* For patients with a breast cancer: patient already under current therapy",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}